Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart procedure shows promise in freeing patients from irregular heartbeat
Disease control CompletedThis study tested a new device that uses electrical pulses to treat a type of irregular heartbeat called paroxysmal atrial fibrillation. 142 people who had not responded to medication took part. The goal was to see if the procedure could keep their heart rhythm normal for a year …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 17, 2026 13:59 UTC
-
New catheter shows promise for taming erratic heart rhythm
Disease control CompletedThis study tested a special catheter device to treat people with a type of irregular heartbeat called paroxysmal atrial fibrillation that didn't get better with medication. The device uses energy to isolate the veins that trigger the abnormal rhythm. Researchers measured safety b…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New balloon device zaps AFib in landmark trial
Disease control CompletedThis study tested a special balloon catheter that uses radiofrequency energy to treat people with a heart rhythm problem called paroxysmal atrial fibrillation (AFib). The device aims to safely and effectively stop AFib episodes by creating small scars in the heart to block faulty…
Phase: PHASE3 • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New heart catheter shows promise for stopping AFib episodes
Disease control CompletedThis study tested a special catheter and generator system to treat people with paroxysmal atrial fibrillation (AFib), a condition that causes irregular heartbeats. The treatment uses heat energy to isolate the veins that trigger AFib. 135 participants who did not respond to medic…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThis study tested a new device (OMNYPULSE catheter with TRUPULSE generator) to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. 188 participants received the procedure to isolate the lung veins. The study measured safety (side effects within 7 days) and effect…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC